This is why new research looks at the potential of a cannabis compound called cannabidiol (CBD) for treating the more challenging symptoms of schizophrenia.
The new study - published in the journal Nature - was carried out by a team of researchers from the Illawarra Health and Medical Research Institute (IHMRI) in New South Wales, Australia.
Uncovering the therapeutic potential of CBD
CBD can affect learning, memory, and attention, which suggests that the compound could help manage cognitive symptoms more effectively and with fewer side effects than widely available medication.
The researchers - led by Dr. Katrina Green from the University of Wollongong, Australia - first discovered the therapeutic value of CBD when they previously conducted a review of 27 studies.
“From this review, we found that CBD will not improve learning and memory in healthy brains, but may improve aspects of learning and memory in illnesses associated with cognitive impairment, including Alzheimer’s disease, as well as neurological and neuro-inflammatory disorders,” explains Dr. Green.
Read full story here: